Search

everythinglearnresearchcommunity

for

Search:↓

15.33% of young Caucasian men have severe hair loss, with higher rates in Jewish men and links to age, BMI, and possibly metabolic syndrome.

Metformin and thiazolidinediones are similarly effective for PCOS, but metformin is often preferred due to fewer side effects.

Hair steroid measurement is an effective method to diagnose and monitor CAH in developing countries.

People with androgenetic alopecia have a higher risk of metabolic syndrome.

Hair loss reduces hair thickness and coverage, but drug treatments mainly revive dormant hairs rather than reverse thinning; patients often undervalue their hair loss severity.

Polycystic ovary syndrome (PCOS) lowers women's quality of life, especially mentally and socially, but nursing guidelines can improve their understanding of the condition.

New treatment reduces hair shedding and increases hair density in women with early hair loss.

People with PCOS have higher levels of PAI-1, which may increase their risk of heart disease and fertility issues.

Young female athletes should be informed about health risks like menstrual issues and bone problems from excessive sports.

Many young Egyptian women with PCOS also have fatty liver disease, especially if they are overweight and insulin resistant.

The Fatty Liver Index (FLI) may not be enough to rule out non-alcoholic fatty liver disease in lean women with polycystic ovary syndrome.

Over half of postmenopausal women experience hair loss, with severity increasing with age, time since menopause, and higher body mass index.

Unhealthy lifestyle and diet may increase the risk of early hair loss in young men.

Acne in adult women is often linked to polycystic ovary syndrome, especially in those who are younger, have premenstrual acne flare-ups, and irregular periods.

Women with Polycystic Ovary Syndrome (PCOS) have a lower health-related quality of life, especially those with an anovulatory phenotype, and need specific interventions to improve it.

Early balding, premature graying, and hair thinning can predict heart disease in young Asian males.

Women with premature ovarian insufficiency have a worse cardiovascular risk profile than premenopausal women.

Obese women with PCOS have lower zinc levels than non-obese ones.

Obesity may worsen hair loss in men and increase hirsutism in overweight or obese individuals, with weight loss recommended for treatment.

Women with PCOS and higher BMI, especially those with morbid obesity, are at greater risk for depression.

The Cross-section Trichometer is a promising tool for measuring hair characteristics without cutting the hair and may have various clinical uses.

Women with excessive body hair often have higher male hormones and related health issues.

Fertility-preserving surgery can help women with early-stage Sertoli-Leydig cell tumors conceive naturally.

Anthropometric measurements like weight and BMI may help identify alopecia risk groups.

Ovarian volume is significantly related to higher levels of certain hormones in Korean women with PCOS.

Myo-inositol and D-chiro-inositol improve hormonal and physical symptoms in teenage girls with PCOS.

Many women with polycystic ovary syndrome have normal blood sugar, but some may have higher blood sugar levels or diabetes, especially if they are older, overweight, and have certain hormone levels.

Normal BMI is linked to higher rates of androgenetic alopecia.

Some overweight or obese men with long-term frontal fibrosing alopecia may have abnormal sex hormone levels.

Clinical signs of hyperandrogenism are related to female pattern hair loss severity, but biochemical markers are not.